Posted 3/25/2024
Scientists and clinicians whose discoveries have shaped the understanding of HIV disease will provide updates on the...
Posted 2/22/2024
There are many paths for women to travel to find success in science. That was a crucial theme conveyed by the four...
Posted 2/7/2024
Frederick National Laboratory researchers identified a vitamin A derivative (retinoid) that when combined with a...
All News
Collaboration with the London School of Hygiene & Tropical Medicine investigates a single-dose HPV vaccine in Tanzania
Posted 6/1/2020Is a single dose of a human papillomavirus (HPV) vaccine sufficient to induce an immune response capable of preventing HPV infection and cervical cancer? That is an area of focus of the Frederick National Laboratory’s HPV Serology Laboratory, this time with a new collaboration with the London School of Hygiene & Tropical Medicine School to investigate immune responses…
FNL supports website development for official COVID-19 treatment guidelines
Posted 5/28/2020As COVID-19 spread around the U.S., health care providers needed guidelines to treat patients—and they needed them fast.
The solution? A website that would house data- and expert-backed clinical treatment guidelines devised by a panel of U.S. physicians, statisticians, and other experts from the National Institutes of Health (NIH), universities, and health care…
Ebola clinical trial supported by FNL receives “Trial of the Year” award
Posted 5/26/2020The Pamoja Tulinde Maisha (PALM, Kiswahili for “together save lives”) trial, a large Ebola research effort supported by the Frederick National Laboratory, has received the David Sackett Trial of the Year Award for 2019.
Ian Crozier, M.D., Frederick National Laboratory/NIAID, administers supportive care and an experimental treatment to a patient in one of the Ebola…
Study on “rapid autopsy” tumor tissue as a valuable research tool is among abstracts presented at 2020 ASCO Virtual Scientific Program
Posted 5/25/2020Tissue obtained from tumors during an autopsy conducted shortly after a cancer patient’s death provides unique insights into how the tumors evolved, spread and resisted treatment. The Frederick National Laboratory’s Molecular Characterization Laboratory reports on results of a study on preclinical models established from “rapid autopsy” tumors during the 2020 American Society…
The Frederick National Laboratory for Cancer Research and COVID-19 serology testing
Vaccine, Immunity, and Cancer DirectoratePosted 5/5/2020In its urgent efforts to confront the novel coronavirus, the U.S. Food and Drug Administration (FDA) has tapped the Frederick National Laboratory for Cancer Research (FNL) to scientifically inform its decision-making on potential approval of blood tests for the presence of antibodies to SARS-CoV-2.
FNL has an adaptive cancer research infrastructure and longstanding…
FNL Team Places Among Top Three in International Computing Contest
Posted 5/3/2020Three employees from Frederick National Laboratory’s Imaging and Visualization Group recently claimed a top spot of a computing and artificial intelligence challenge that attracted 170 competing groups from around the world.
The team—Yanling Liu, Ph.D.; Hyun Jung, Ph.D.; and G. Tom Brown, M.D., Ph.D.—took third place overall and was the top group in the “Industry” category…
FNL RAS Investigators Take Published KRAS Study a Step Further, Share Findings in PNAS Letter to Editor
Posted 4/27/2020A scientific paper on a member of the RAS family of oncogenes published last summer so intrigued Frederick National Laboratory computational scientist Trent Balius that he and his and colleagues performed a follow-up study, shedding more light on the topic.
Balius and FNL colleagues in the National Cancer Institute’s RAS Initiative shared their findings as a letter to the…
Building an interdisciplinary pain medicine and palliative care program in Ethiopia
Posted 4/12/2020
Cancer is beginning to eclipse infectious disease as a major cause of mortality in low-to-middle income countries like those in sub-Saharan Africa. In Ethiopia, people with cancer who reach a hospital are diagnosed with advanced disease for which there is little treatment available and practically nothing to stem their unbearable disease-related pain. The Ethiopian…
Building an interdisciplinary pain medicine and palliative care program in Ethiopia
Posted 4/12/2020Cancer is beginning to eclipse infectious disease as a major cause of mortality in low-to-middle income countries like those in sub-Saharan Africa. In Ethiopia, people with cancer who reach a hospital are diagnosed with advanced disease for which there is little treatment available and practically nothing to stem their unbearable disease-related pain. The Ethiopian government…
Trans-NIH Study Shows HPV Vaccine Benefits Women Following Donor Stem Cell Transplant
Posted 2/27/2020Immune Response Induced by Vaccination May Lower Risk of New HPV Infections and Associated HPV-Related Cancers in Post-Transplant Women
Women who completed a three-dose series of the HPV vaccine following a donor stem cell transplant developed a surprisingly robust immune response to vaccination, which was not significantly different from the responses in healthy women.…
Media Inquiries
For all media related questions please contact:
Mary Ellen Hackett
Manager, Communications Office